TRUMP’S TARIFF TERROR RETURNS
Trump announces a new tariff roadmap for generic drug imports.
0% tariff on generic drugs from August 1, 2026 for 2 years.
Tariff jumps to 100% from August 2028 for one year.
Tariff doubles to 200% from August 2029 onwards.
Goal: Push pharmaceutical companies to manufacture in the United States.
Companies that fail to build manufacturing facilities in the U.S. could face steep import penalties.
Policy applies only to generic drugs.
Patented, branded and innovative medicines remain unaffected.
Trump says the move will strengthen U.S. manufacturing and reduce dependence on imports.
India, one of the world’s largest suppliers of generic medicines to the U.S., could face significant long-term implications if production is not shifted.
Pharma companies now have a two-year window to reassess manufacturing and supply-chain strategies.
Markets may closely track the impact on Indian pharma exporters and U.S. healthcare costs.
Key Dates
Aug 1, 2026 – Jul 31, 2028: 0% tariff
Aug 1, 2028 – Jul 31, 2029: 100% tariff
From Aug 1, 2029: 200% tariff
@_anujsinghal #TrumpTariff #pharma
#stockmarket #sharemarket #cnbcawaaz #marketnews #latestbusinessnews | Personal Finance | Market | Budget2026 | Nirmala Sitharaman
CNBC Awaaz brings to you latest business news, live share market updates, stock market updates, top business news in india, stock market updates, IPO latest updates, news updates on banking and financials, realty sector and it sector. Watch business news live, business news and share market live updates on CNBC Awaaz. Stay tune to get all the news of pre-opening trades, opening trades, and top calls in pehla sauda. Know what market veterans have to say on the current market trends in Big Market Voices.
CNBC Awaaz is one of India’s leading business channels and has been a trusted source for business news and information for over 21 years. Our channel is dedicated to educating, informing, and inspiring viewers to overcome limitations by providing practical advice on personal finance, investing, technology, consumer goods, and capital markets. Policymakers and business owners alike rely on CNBC Awaaz for its accurate and insightful coverage of India’s business environment. Our programming empowers consumers with the knowledge they need to make confident decisions. Stay informed with detailed insights on real estate, stocks, mutual funds, and more.
Main URL: https://www.youtube.com/watch?v=i_1g_M0JSy4
Subscribe to the CNBC Awaaz channel and press the bell icon to get notified when we go live: https://tinyurl.com/y5rsvesk
Twitter: https://twitter.com/CNBC_Awaaz
Facebook page: https://www.facebook.com/cnbcawaaz
Website: https://hindi.cnbctv18.com/
Whatsapp Link: http://bit.ly/3RiTpSc
Instagram: https://www.instagram.com/cnbcawaaz/
source
